Home / Knowledge Centre /
Case study

Almac ONE™ aligns communications ensuring visibility and accuracy throughout phase I oncology study

For one global biotechnology company, unifying the digital and physical aspects of its supply chain would prove essential in bridging the data gap and optimising operations for its phase I oncology study.

Traditionally, sponsors outsource the digital (IRT) and physical (clinical supplies) aspects of the clinical supply chain to multiple vendors. While this may sometimes offer initial cost benefits, it often represents a false economy. This is because vital information can fall through the gaps between where one vendor’s responsibility ends and another’s begins.

Download our case study to discover how one biotechnology benefited from immediate alignment of its physical and digital operations by using Almac ONE™; a unified supply chain solution.

View Resource
Almac Logo

Almac Clinical Services

Guided by our extensive clinical supply experience and expertise, Almac Clinical Services  is  recognised as an innovative,  global solution provider within the specialised and complex market of clinical trial supply.

Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.

Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies